Circle Wealth Management LLC Makes New Investment in Tempus AI, Inc. (NASDAQ:TEM)

Circle Wealth Management LLC bought a new stake in shares of Tempus AI, Inc. (NASDAQ:TEM) in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 7,503 shares of the company’s stock, valued at approximately $253,000.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. ARK Investment Management LLC lifted its position in shares of Tempus AI by 132.1% in the 4th quarter. ARK Investment Management LLC now owns 5,519,644 shares of the company’s stock worth $186,343,000 after purchasing an additional 3,141,487 shares during the period. Sumitomo Mitsui Trust Group Inc. boosted its position in Tempus AI by 166.0% during the 4th quarter. Sumitomo Mitsui Trust Group Inc. now owns 3,239,093 shares of the company’s stock valued at $109,352,000 after acquiring an additional 2,021,394 shares in the last quarter. Nikko Asset Management Americas Inc. increased its holdings in shares of Tempus AI by 166.0% in the 4th quarter. Nikko Asset Management Americas Inc. now owns 3,239,093 shares of the company’s stock valued at $109,352,000 after acquiring an additional 2,021,394 shares during the period. Franklin Resources Inc. grew its stake in Tempus AI by 240.5% in the fourth quarter. Franklin Resources Inc. now owns 2,762,173 shares of the company’s stock valued at $93,251,000 after purchasing an additional 1,950,862 shares during the last quarter. Finally, JPMorgan Chase & Co. lifted its position in shares of Tempus AI by 86,947.2% during the fourth quarter. JPMorgan Chase & Co. now owns 1,653,896 shares of the company’s stock valued at $55,836,000 after buying an additional 1,651,996 shares during the last quarter. Institutional investors own 24.22% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts have weighed in on the stock. BTIG Research started coverage on shares of Tempus AI in a research note on Monday, April 21st. They issued a “buy” rating and a $60.00 target price for the company. Wolfe Research cut Tempus AI from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, February 26th. William Blair restated a “market perform” rating on shares of Tempus AI in a report on Tuesday, February 25th. Guggenheim reiterated a “buy” rating on shares of Tempus AI in a research note on Tuesday, February 25th. Finally, Loop Capital lowered their price objective on shares of Tempus AI from $57.00 to $52.00 and set a “buy” rating for the company in a research note on Tuesday, January 14th. Six equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. According to MarketBeat, Tempus AI presently has an average rating of “Moderate Buy” and an average target price of $61.08.

Tempus AI Stock Performance

Shares of TEM stock opened at $65.22 on Friday. The company has a current ratio of 2.69, a quick ratio of 2.55 and a debt-to-equity ratio of 8.17. The business’s 50 day moving average is $48.22 and its two-hundred day moving average is $50.87. Tempus AI, Inc. has a 12-month low of $22.89 and a 12-month high of $91.45.

Tempus AI (NASDAQ:TEM) last posted its quarterly earnings data on Tuesday, May 6th. The company reported ($0.24) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.27) by $0.03. The company had revenue of $255.74 million for the quarter, compared to analyst estimates of $248.13 million. The business’s revenue was up 75.4% compared to the same quarter last year. On average, equities analysts expect that Tempus AI, Inc. will post -6.15 earnings per share for the current fiscal year.

Insider Buying and Selling

In other news, COO Ryan Fukushima sold 20,000 shares of the business’s stock in a transaction dated Tuesday, May 6th. The shares were sold at an average price of $52.36, for a total transaction of $1,047,200.00. Following the transaction, the chief operating officer now owns 884,460 shares of the company’s stock, valued at approximately $46,310,325.60. The trade was a 2.21 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, EVP Erik Phelps sold 61,582 shares of Tempus AI stock in a transaction dated Tuesday, February 18th. The stock was sold at an average price of $82.36, for a total transaction of $5,071,893.52. Following the transaction, the executive vice president now directly owns 153,080 shares in the company, valued at $12,607,668.80. This trade represents a 28.69 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 4,237,561 shares of company stock worth $251,210,331. 27.60% of the stock is owned by insiders.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.